Hematopoietic stem cell-derived myeloid and plasmacytoid DC-based vaccines are highly potent inducers of tumor-reactive T cell and NK cell responses ex vivo

Thordardottir, S.; Schaap, N.; Louer, E.; Kester, M.G.D.; Falkenburg, J.H.F.; Jansen, J.; ... ; Dolstra, H. (2017)

Article / Letter to editor

• Antitumor immunity
• dendritic cells
• graft-versus-tumor immunity
• hematopoietic stem and progenitor cell
• mDC
• NK cell
• pDC
• T cell
• vaccination

• All authors: Thordardottir, S.; Schaap, N.; Louer, E.; Kester, M.G.D.; Falkenburg, J.H.F.; Jansen, J.; Radstake, T.R.D.; Hobo, W.; Dolstra, H.
• Date: 2017-12-31
• Journal: OncoImmunology
• Volume: 6
• Issue: 3
• DOI: doi:10.1080/2162402X.2017.1285991